LDN 212320 is a small molecule activator of glutamate transporter EAAT2 translation, which provides neuroprotection and shows potential for the therapeutic treatment of neurodegenerative diseases.
Kong, Q.; et al.: J. Clin. Investig., 124, 1255 (2014)
400-821-0725
沪ICP备17019645号
